Find the right Medicare plan for 2025 — compare coverage and costs in minutes.

Compare Medicare Plans →
Senior Health MedPageToday.com - medical news for physicians

Brain Disorders and TBI May Fuel Each Other

(MedPage Today) -- The connection between traumatic brain injury (TBI) and neurologic disorders may run both ways, a large retrospective study of U.S. military veterans suggested. Older adults with TBI were more likely than those without TBI to...

Read full article →
Senior Health MedPageToday.com - medical news for physicians

Reddit Chatter Signaled Virus Surge in World Cup Host City

(MedPage Today) -- Public health surveillance tactics in place for the FIFA World Cup identified and confirmed a gastrointestinal virus surge in a host city. The Health Security Operations Center (HSOC) has been leading an independent and collaborative...

Read full article →
Industry News Healthcare News

FDA panel recommends mRNA flu vaccine for older adults

A first-of-its-kind flu shot is one step closer to being available to the public after a Food and Drug Administration (FDA) advisory panel voted Thursday to recommend Moderna’s mRNA-based vaccine for approval. The FDA’s independent vaccine advisors voted unanimously 9-0 that the benefits outweigh the risks for Moderna’s mFlusiva shot in people ages 50 to 64 as well as 65 and older. Moderna is...

Read full article →
Industry News Healthcare News

Ebola outbreak zone cases up almost 40 percent in a week

The Ebola outbreak in Congo that’s spread across parts of Africa has killed more than 200 people in its first month and is considered the worst known outbreak at this stage, the Africa Centres for Disease Control and Prevention (Africa CDC) said Thursday. Ebola cases have surged 38 percent since last week, spreading across 32...

Read full article →
Medicare News MedCity News

Kardigan’s IPO Lands $400M for Drugs That Get to Root Causes of Heart Diseases

Kardigan was able to upsize its IPO, raising more cash for three drug candidates in mid-stage clinical development for cardiovascular conditions with no available therapies. All three programs are expected to report key data in 2027 that could pave the way for Phase 3 testing. The post Kardigan’s IPO Lands $400M for Drugs That Get to Root Causes of Heart Diseases appeared first on MedCity News .

Read full article →